Home Cellink

Cellink

In operation
Post-IPO Round
Biotechnology Developer
Basic
Enterprise Profile

Basic Information

Cellink is a biotechnology company and one of the world's earliest bio-ink companies. The company uses its bio-ink and 3D printing technology to print human organ and tissue models, which have the potential to be used in cancer research, drug testing, and cosmetic testing. The company's vision is to create the future of medicine by making bioprinting technology as convenient, user-friendly, and high-performing as possible. Cellink has offices in Gothenburg, Sweden, and Palo Alto, California, and collaborates with various organizations worldwide.
CELLINK AB.
Cambridge,Massachusetts,United States of America
101~500 people
January 27, 2016
info@cellink.com

Enterprise Profile

Industrial Sector
New Drug Development Scientific Research and Experimental Development Services Biological Product Manufacturing
Technology
3D Printing
Concept
Tumor
Application Scenarios
Innovative Drugs